News
Leqembi has been approved in the European Union for the treatment of certain adults with early Alzheimer's disease and mild ...
Barchart on MSN12h
Earnings Preview: What To Expect From Biogen's ReportWith a market cap of $17.4 billion, Biogen Inc. (BIIB) is a global biotechnology leader focused on discovering, developing, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback